We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...

A product made in Columbus reached a major milestone at the end of 2024. Ensure, a nutritional drink made by Abbott ...

As the demand for these granules increased, so did Abbott Alkaloidal Company, and one of the world's most broad-based healthcare companies was born. By 1910, there were over 700 new products in ...

“Abbott’s representations of its toddler nutrition products are accurate, and our claims are well-supported.” The class action suit wants Abbott to change its marketing practices and return ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...

Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support improvements in overall health and wellness.

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...

Cancer is the second leading cause of death across the globe, second to cardiovascular disease. According to data by the ...

A legal research organization focused on public health says Abbott Laboratories' marketing of "toddler milk" products to children age 12 months to 36 months as "natural and healthy" is misleading.